X4 Pharmaceuticals, Inc financial data

Symbol
XFOR on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 393% % -22%
Debt-to-equity 393% % 83%
Return On Equity -344% % -957%
Return On Assets -70% % -575%
Operating Margin -291% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87,436,688 shares -49%
Common Stock, Shares, Outstanding 25,146,411 shares -85%
Entity Public Float $96,000,000 USD -70%
Common Stock, Value, Issued $25,000 USD -85%
Weighted Average Number of Shares Outstanding, Basic 43,272,773 shares 546%
Weighted Average Number of Shares Outstanding, Diluted 43,272,773 shares 546%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,566,000 USD 180%
Revenue from Contract with Customer, Excluding Assessed Tax $33,979,000 USD 215%
Cost of Revenue $5,695,000 USD 55%
Research and Development Expense $75,904,000 USD 0.92%
General and Administrative Expense $51,279,000 USD -8.9%
Operating Income (Loss) $98,899,000 USD -282%
Nonoperating Income (Expense) $4,103,000 USD -55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $94,796,000 USD -469%
Income Tax Expense (Benefit) $299,000 USD 252%
Net Income (Loss) Attributable to Parent $95,095,000 USD -467%
Earnings Per Share, Basic -4 USD/shares -1822%
Earnings Per Share, Diluted -4 USD/shares -1952%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $69,632,000 USD -29%
Cash, Cash Equivalents, and Short-term Investments $122,200,000 USD -9.5%
Accounts Receivable, after Allowance for Credit Loss, Current $891,000 USD
Inventory, Net $2,817,000 USD
Assets, Current $132,805,000 USD -7.1%
Property, Plant and Equipment, Net $218,000 USD -73%
Operating Lease, Right-of-Use Asset $1,775,000 USD -60%
Goodwill $17,351,000 USD 0%
Other Assets, Noncurrent $1,968,000 USD -17%
Assets $163,555,000 USD -8.2%
Accounts Payable, Current $5,053,000 USD -41%
Employee-related Liabilities, Current $8,344,000 USD -9.4%
Accrued Liabilities, Current $16,661,000 USD -14%
Contract with Customer, Liability, Current $592,000 USD
Liabilities, Current $23,506,000 USD -20%
Contract with Customer, Liability, Noncurrent $789,000 USD
Operating Lease, Liability, Noncurrent $95,000 USD -95%
Other Liabilities, Noncurrent $525,000 USD -57%
Liabilities $101,936,000 USD -14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $118,000 USD -3.5%
Retained Earnings (Accumulated Deficit) $570,629,000 USD -20%
Stockholders' Equity Attributable to Parent $61,619,000 USD 3.4%
Liabilities and Equity $163,555,000 USD -8.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,368,000 USD 63%
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $3,138,000 USD 41%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 25,146,411 shares -85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $15,434,000 USD 60%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $70,435,000 USD -28%
Deferred Tax Assets, Valuation Allowance $184,908,000 USD 13%
Deferred Tax Assets, Gross $185,686,000 USD 12%
Operating Lease, Liability $1,295,000 USD -57%
Depreciation $289,000 USD 366%
Lessee, Operating Lease, Liability, to be Paid $1,386,000 USD -60%
Property, Plant and Equipment, Gross $1,415,000 USD -44%
Operating Lease, Liability, Current $1,200,000 USD -1.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $306,000 USD -77%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,053,000 USD -26%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $91,000 USD -81%
Lessee, Operating Lease, Liability, to be Paid, Year Three $51,000 USD -82%
Deferred Tax Assets, Operating Loss Carryforwards $115,332,000 USD -6.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Unrecognized Tax Benefits $200,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $45,000 USD -84%
Operating Lease, Payments $1,410,000 USD 2.1%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) $0 USD
Current Federal Tax Expense (Benefit) $0 USD
Amortization of Intangible Assets $200,000 USD
Depreciation, Depletion and Amortization $476,000 USD 668%
Deferred Tax Assets, Net of Valuation Allowance $778,000 USD -32%
Share-based Payment Arrangement, Expense $4,244,000 USD -50%
Interest Expense $8,350,000 USD 66%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares